UNSPSC 51131643: Indobufen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C18H17NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6T9949G4LZ, chemically known as 4-(1,3-dihydro-1-oxo-2h-isoindol-2-yl)-alpha-ethylbenzeneacetic acid but generally known as indobufen, which bears US NIH Compound Identifier 107641. European Medicines Agency schedules Indobufen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08176MIG.

UNSPSC 51131643 Indobufen is a Commodity code that does not align with the recent state and local procurement activity tagged under it. The only recent opportunity on record — Sourcewell RFP #061626, posted May 12, 2026 with a June 16, 2026 response deadline — solicits law enforcement equipment through a multi-state cooperative purchasing vehicle; indobufen, a pharmaceutical antiplatelet agent, bears no relationship to law enforcement equipment procurement. The code shows little relevant recent activity in state and local contracting.

Sourcewell, a Minnesota local government unit and service cooperative, issued the RFP on behalf of participating entities across Washington state (Franklin, Grant, Grays Harbor, Chelan, and Yakima Counties) and numerous other jurisdictions throughout the United States and Canada. The resulting contract was intended to establish a framework available to thousands of governmental agencies, higher education institutions, school districts, nonprofit organizations, tribal governments, and other public entities. Proposals were due June 16, 2026 at 3:30 p.m. Central Time through the Sourcewell Procurement Portal. The mismatch between the code's pharmaceutical scope and the actual solicitation content suggests the tagging may reflect a data error rather than genuine procurement activity under this Commodity code.